Double Hit/Double Expressor Lymphomas: A Multicenter Analysis of Survival Outcomes with CD19-Directed CAR T-Cell Therapy
Year: 2022
Type: article
Source: Blood
Authors: Joanna Zurko, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason T. Romancik, Imran A. Nizamuddin, Kaitlin Annunzio, Jieqi Liu, Stefan K. Barta, Robert Ferdman, Rahul Bhansali, Jonathon B. Cohen, Sayan Mullick Chowdhury, Nirav N. Shah, Elyse I. Harris, Vaishalee P. Kenkre, McKenzie Sorrell, Brian T. Hess, Deborah M. Stephens, Lindsey A. Fitzgerald, Thomas A. Ollila, Ishan Roy, Shuo Ma, Jane N. Winter, Barbara Pro, Jonathan Moreira, Leo I. Gordon, Alexey V Danilov, Andrew M. Evens, Narendranath Epperla, Reem Karmali
Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, City Of Hope National Medical Center, Roswell Park Comprehensive Cancer Center, Levine Cancer Institute, Emory University, Winship Cancer Institute, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, The Ohio State University, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Abramson Cancer Center, University of Pennsylvania, The Ohio State University Wexner Medical Center, Medical College of Wisconsin, Medical University of South Carolina, MUSC Hollings Cancer Center, Huntsman Cancer Institute, University of Utah, Brown University, Lifespan, City of Hope, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310163299